De Barsy syndrome

Not Verified
This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes

Disease overview

Genetic disorder that affects connective tissue leading to loose, sagging, inelastic skin (more info)

Common symptoms

Prematurely-aged appearanceloose wrinkled skin without elasticityeye abnormalitiesgrowth retardationintellectual disabilitydistinctive facial features including frontal bossinghypertelorisma small upturned noseand large malformed earshypotoniamicrocephaly

WHEN TO SUSPECT

  • Recommendation 1

    Biopsy of affected skin can reveal characteristic changes in elastic fibers and molecular genetic testing can confirm a diagnosis of inherited cutis laxa. Purine synthesis defect metabolites should also be screened for in case of ALDH18A1 mutation-related cases

HOW TO TEST

  • Recommendation 1

    Biopsy of affected skin can reveal characteristic changes in elastic fibers and molecular genetic testing can confirm a diagnosis of inherited cutis laxa. Purine synthesis defect metabolites should also be screened for in case of ALDH18A1 mutation-related cases

TREATMENT

  • Recommendation 1

    Surgery can repair skeletal problems, ocular abnormalities, and hernias. Individuals with ALDH18A1-related de Barsy syndrome should be treated by ammonia scavengers as well as supplementation with citrulline or arginine

PRIMARY CARE

  • Recommendation 1

    Early developmental intervention, physiotherapy, avoidance of environmental triggers (e.g. sunbathing)

FURTHER SUPPORT

  • Recommendation 1

    Pediatricians, surgeons, dermatologists, orthopedists, neurologists, ophthalmologists. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.

CLINICAL TRIALS

  • Recommendation 1

    No clinical trials currently recruiting

Sources

No data available

Interested in learning more about De Barsy syndrome?

Follow to receive regular updates to the latest research development on this disease via email newsletter.